SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 125 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,797,424 | +2.5% | 423,764 | +16.2% | 0.00% | 0.0% |
Q2 2023 | $9,560,494 | +19.3% | 364,626 | +17.1% | 0.00% | +50.0% |
Q1 2023 | $8,014,895 | -0.9% | 311,379 | +0.1% | 0.00% | -33.3% |
Q4 2022 | $8,088,460 | +19.3% | 310,975 | +30.9% | 0.00% | +50.0% |
Q3 2022 | $6,778,000 | +33.6% | 237,543 | +15.3% | 0.00% | 0.0% |
Q2 2022 | $5,072,000 | -54.5% | 205,983 | +4.2% | 0.00% | -33.3% |
Q1 2022 | $11,154,000 | -5.9% | 197,624 | +3.3% | 0.00% | -25.0% |
Q4 2021 | $11,855,000 | -0.7% | 191,259 | +1.6% | 0.00% | 0.0% |
Q3 2021 | $11,942,000 | -25.0% | 188,230 | -2.5% | 0.00% | -20.0% |
Q2 2021 | $15,917,000 | +20.3% | 193,144 | +7.4% | 0.01% | 0.0% |
Q1 2021 | $13,227,000 | +4.9% | 179,786 | +3.4% | 0.01% | 0.0% |
Q4 2020 | $12,609,000 | +86.9% | 173,866 | +22.9% | 0.01% | +66.7% |
Q3 2020 | $6,746,000 | +83.9% | 141,508 | +62.1% | 0.00% | +50.0% |
Q2 2020 | $3,668,000 | +125.4% | 87,321 | +44.9% | 0.00% | +100.0% |
Q1 2020 | $1,627,000 | -28.3% | 60,244 | +2.2% | 0.00% | 0.0% |
Q4 2019 | $2,269,000 | – | 58,931 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 3,081,307 | $79,313 | 9.91% |
Finepoint Capital LP | 614,231 | $15,810,306 | 6.04% |
M28 Capital Management LP | 197,700 | $5,088,798 | 5.75% |
Boxer Capital, LLC | 3,421,541 | $88,070 | 4.33% |
Deep Track Capital, LP | 3,100,000 | $79,794,000 | 3.28% |
EcoR1 Capital, LLC | 3,460,208 | $89,065,754 | 2.87% |
Artal Group S.A. | 1,817,349 | $46,779 | 2.78% |
Orbimed Advisors | 4,498,900 | $115,801,686 | 2.27% |
Perceptive Advisors | 2,079,352 | $53,522,520 | 1.58% |
SPHERA FUNDS MANAGEMENT LTD. | 317,625 | $8,175,668 | 1.37% |